(Q40180061)

18 September 2017

Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression (English)

1 reference

18 September 2017

1 reference

1 reference

3

Masashi Mizuguchi

1 reference

18 September 2017

Yuyan Chen

1

1 reference

18 September 2017

Junko Takita

2

1 reference

18 September 2017

Kiyoshi Tanaka

4

1 reference

18 September 2017

Kohmei Ida

5

1 reference

18 September 2017

Katsuyoshi Koh

6

1 reference

18 September 2017

Takashi Igarashi

7

1 reference

18 September 2017

Ryoji Hanada

8

1 reference

18 September 2017

Yukichi Tanaka

9

1 reference

18 September 2017

Myoung-Ja Park

10

1 reference

18 September 2017

Yasuhide Hayashi

11

1 reference

18 September 2017

1 April 2007

1 reference

Genes, Chromosomes and Cancer

18 September 2017

1 reference

18 September 2017

46

1 reference

18 September 2017

348-358

1 reference

18 September 2017

4

1 reference

Emerging multipotent aspects of hepatocyte growth factor

18 September 2017

1 reference

Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations

21 January 2018

1 reference

Met, metastasis, motility and more

21 January 2018

1 reference

7 January 2021

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

1 reference

7 January 2021

The formation of skeletal muscle: from somite to limb

1 reference

7 January 2021

Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies

1 reference

7 January 2021

Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee

1 reference

7 January 2021

p16(INK4a) immunocytochemical analysis is an independent prognostic factor in childhood acute lymphoblastic leukemia

1 reference

7 January 2021

Pax3 modulates expression of the c-Met receptor during limb muscle development

1 reference

7 January 2021

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

1 reference

7 January 2021

Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcoma

1 reference

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

7 January 2021

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.

1 reference

7 January 2021

Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.

1 reference

7 January 2021

Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors

1 reference

7 January 2021

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours

1 reference

7 January 2021

Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia

1 reference

7 January 2021

Rhabdomyosarcoma--working out the pathways

1 reference

7 January 2021

Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study

1 reference

7 January 2021

Mutations and altered expression of p16INK4 in human cancer.

1 reference

7 January 2021

Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus

1 reference

7 January 2021

Scatter factor/hepatocyte growth factor is essential for liver development

1 reference

7 January 2021

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

1 reference

7 January 2021

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis.

1 reference

7 January 2021

The INK4a/ARF network in tumour suppression

1 reference

7 January 2021

t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines

1 reference

7 January 2021

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

1 reference

7 January 2021

Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

1 reference

7 January 2021

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

1 reference

7 January 2021

Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis.

1 reference

7 January 2021

The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients

1 reference

7 January 2021

Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma.

1 reference

7 January 2021

Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.

1 reference

7 January 2021

Scatter-factor and semaphorin receptors: cell signalling for invasive growth

1 reference

7 January 2021

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

1 reference

7 January 2021

Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors

1 reference

7 January 2021

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20416

1 reference

18 September 2017

1 reference